BAFNA PHARMACEUTICALS
|
BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹11 Cr | ₹4.15 Cr | ₹7.35 Cr | ₹12 Cr | ₹5.19 Cr |
| Adjustment | ₹9.68 Cr | ₹10 Cr | ₹7.59 Cr | ₹7.88 Cr | ₹5.50 Cr |
| Changes In working Capital | ₹-5.60 Cr | ₹7.55 Cr | ₹-5.28 Cr | ₹-14 Cr | ₹-0.80 Cr |
| Cash Flow after changes in Working Capital | ₹15 Cr | ₹22 Cr | ₹9.66 Cr | ₹5.08 Cr | ₹9.90 Cr |
| Cash Flow from Operating Activities | ₹15 Cr | ₹22 Cr | ₹9.48 Cr | ₹4.95 Cr | ₹9.73 Cr |
| Cash Flow from Investing Activities | ₹-22 Cr | ₹-21 Cr | ₹-15 Cr | ₹-7.49 Cr | ₹-6.54 Cr |
| Cash Flow from Financing Activities | ₹5.62 Cr | ₹1.06 Cr | ₹-0.85 Cr | ₹10 Cr | ₹-4.81 Cr |
| Net Cash Inflow / Outflow | ₹-1.41 Cr | ₹2.04 Cr | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr |
| Opening Cash & Cash Equivalents | ₹3.43 Cr | ₹1.40 Cr | ₹7.81 Cr | ₹0.17 Cr | ₹1.80 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹2.02 Cr | ₹3.43 Cr | ₹1.40 Cr | ₹7.81 Cr | ₹0.17 Cr |
Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹717.0 Cr | 11.6% | 10.8% | 258% | Stock Analytics | |
| No other companies found in this Industry | ||||||
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 11.6% |
10.8% |
258% |
| SENSEX | -1% |
-2.9% |
-4.9% |
You may also like the below Video Courses